# Institute of Oncology Ljubljana

> medical institution in Ljubljana, Slovenia

**Wikidata**: [Q12797927](https://www.wikidata.org/wiki/Q12797927)  
**Source**: https://4ort.xyz/entity/institute-of-oncology-ljubljana

## Summary
The Institute of Oncology Ljubljana is Slovenia’s national cancer research institute, headquartered in Ljubljana. Classified as a research institute, it is the country’s flagship institution for oncology research and is catalogued under the global research identifiers GRID: grid.418872.0 and ROR: 00y5zsg21.

## Key Facts
- Official website: http://www.onko-i.si/
- Located in Ljubljana, Slovenia
- ISNI: 0000 0000 8704 8090
- ROR ID: 00y5zsg21
- GRID ID: grid.418872.0
- VIAF ID: 126185856
- EU VAT number: SI34052674
- EU Participant Identification Code: 986222475
- Ringgold ID: 68196
- CONOR.SI ID: 288300899
- Wikipedia sitelinks: 1 (Slovenian Wikipedia)

## FAQs
### Q: What is the Institute of Oncology Ljubljana?
A: It is Slovenia’s national cancer research institute, based in Ljubljana, and officially registered as a research institute under global research identifiers GRID and ROR.

### Q: Where is the Institute of Oncology Ljubljana located?
A: The institute is located in Ljubljana, the capital city of Slovenia.

### Q: How can I access more information about the Institute of Oncology Ljubljana?
A: Visit the official website at http://www.onko-i.si/ or consult its Wikidata entry and authority files such as VIAF, ISNI, and Library of Congress.

## Why It Matters
As Slovenia’s only national institute dedicated to oncology research, the Institute of Oncology Ljubljana plays a pivotal role in advancing cancer science, patient care, and public-health policy across the country. Its designation as a research institute signals that its core mission is to generate new knowledge about cancer biology, prevention, diagnostics, and treatment. By anchoring Slovenia in the global network of cancer centers—evidenced by its inclusion in authoritative databases such as GRID, ROR, and Ringgold—the institute ensures that Slovenian researchers, clinicians, and patients have access to cutting-edge trials, data-sharing consortia, and evidence-based guidelines. This centralization of expertise reduces duplication of effort, concentrates scarce resources, and accelerates translation of laboratory discoveries into clinical practice, ultimately improving survival and quality of life for cancer patients nationwide.

## Notable For
- Sole Slovenian institute exclusively focused on oncology research
- Listed in all major global research identifier systems (GRID, ROR, ISNI, VIAF)
- Official EU participant identification code (986222475) enabling direct engagement in EU-funded cancer research projects
- Bilingual branding—operates under both English name and Slovene alias “Onkološki Inštitut Ljubljana”
- Maintains a dedicated Slovenian-language Wikipedia page, underscoring its national cultural and scientific prominence

## Body
### Identity and Classification
The Institute of Oncology Ljubljana is catalogued in the Global Research Identifier Database (GRID) as grid.418872.0 and in the Research Organization Registry (ROR) as 00y5zsg21. These persistent identifiers link publications, patents, and grants to a single organizational profile, ensuring transparent tracking of the institute’s scholarly output.

### Location and Jurisdiction
Headquartered in Ljubljana, the institute falls under Slovenian national regulations and reports to Slovenian health authorities. Its EU VAT number (SI34052674) and EU Participant Identification Code (986222475) formalize its status for cross-border research contracts and Horizon Europe proposals.

### Naming Variants
The institute appears in authority files under two primary forms:
- English: Institute of Oncology Ljubljana
- Slovene: Onkološki Inštitut Ljubljana